ARCHIVES

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 7 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: CRCC, One Of The 21 Comprehensive Centers, To Close Up; Steckel New AACI President

January 30, 1981

Rituxan Approved as Maintenance For Advanced Follicular Lymphoma

February 25, 2011

Expiring Program Offer Flexibility

February 12, 1982

NCI Posts Website Usability Research, Information Online.

January 12, 2001

Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials

December 2, 1977

Aventis, MediGene In Pact For Development Of Vaccine.

February 25, 2000